Vietnam Microfluidics Market Outlook to 2028

Vietnam Microfluidics Market Overview

The Vietnam Microfluidics Market has experienced substantial growth, this is reflected by the global microfluidics market was valued at USD 22 billion in 2023, is driven by advancements in healthcare and diagnostics, increasing demand for point-of-care testing, and the rising prevalence of chronic diseases.

The Vietnam microfluidics market is dominated by key players like Danaher Corporation, Perkin Elmer Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., and Fluidigm Corporation. These companies lead the market through continuous innovation, extensive product portfolios, and strategic partnerships.

In 2024, Agilent Technologies Inc. announced the acquisition of a Vietnamese biotech startup specializing in microfluidics technology. This acquisition aims to expand Agilent's product offerings and strengthen its presence in the Southeast Asian market.

In 2023, the southern region of Vietnam, particularly Ho Chi Minh City, dominated the Microfluidics market. The state's dominance is driven by advancements in medical technology and strong collaborations between hospitals and diagnostic companies.

Vietnam Microfluidics Market Segmentation

Vietnam's Microfluidics Market is segmented into product type, application, and region.

By Product Type: Vietnam's microfluidics market is segmented by product type into microfluidic chips, microfluidic pumps, and microfluidic sensors. In 2023, microfluidic chips held the largest market share due to their widespread application in diagnostics and drug development.

By Application: Vietnam's microfluidics market is segmented by application into diagnostics, drug development, and environmental monitoring. Diagnostics remains the dominant application segment in 2023 due to the increasing prevalence of chronic diseases and the demand for rapid, precise diagnostic tools.

By Region: Vietnam Microfluidics market by region is segmented into North, South, East, and West. The South region, with Ho Chi Minh City as its economic hub, dominated the market in 2023, driven by advancements in healthcare infrastructure and technological advancements.

Vietnam Microfluidics Market Competitive Landscape

Company Name

Establishment Year

Headquarters

Danaher Corporation

1969

Washington, D.C., USA

Perkin Elmer Inc.

1937

Waltham, MA, USA

Thermo Fisher Scientific Inc.

2006

Waltham, MA, USA

Agilent Technologies Inc.

1999

Santa Clara, CA, USA

Fluidigm Corporation

1999

South San Francisco, CA, USA

Fluidigm Corporation: In 2023, Fluidigm Corporation announced a strategic collaboration with a leading Vietnamese diagnostic company i.e. Viet Medical Solutions to develop advanced microfluidics-based diagnostic solutions. This partnership aims to enhance diagnostic capabilities in Vietnam, focusing on early detection of infectious diseases, and is expected to boost the market.

Thermo Fisher Scientific Inc.: In 2023, Thermo Fisher Scientific Inc. launched a new microfluidics-based diagnostic platform in Vietnam. This platform improves the accuracy and speed of disease detection, providing healthcare professionals with advanced tools for patient diagnosis. The introduction of such innovative products is driving the growth of the microfluidics market in Vietnam.

Vietnam Microfluidics Market Analysis

Vietnam Microfluidics Market Growth Drivers:

Increasing Prevalence of Chronic Diseases: The rising prevalence of chronic diseases such as diabetes and cardiovascular disorders is a growth driver of the Vietnam microfluidics market. According to the Vietnam Ministry of Health, the number of diabetes patients increased to 4.5 million in 2023 from 3.2 million in 2018, necessitating advanced diagnostic tools for efficient disease management. This trend is expected to continue, with chronic diseases remaining a major healthcare burden, thereby driving the demand for microfluidics-based diagnostic solutions.

Adoption of Point-of-Care Testing: The adoption of point-of-care testing (POCT) is increasing in Vietnam, driven by the need for rapid and accurate diagnostic results. In 2023, the Vietnamese healthcare system conducted over 10 million POCT procedures, highlighting the growing preference for immediate testing solutions. Microfluidics technology, with its ability to provide quick and precise results, is becoming integral to POCT, thus propelling market growth.

Rising Investments in Research and Development: In 2024, Vietnam allocated USD 50 million for biomedical research, focusing on developing advanced diagnostic tools and treatments. This funding is accelerating the development of new microfluidics applications and products, contributing to market expansion. Collaborative efforts between research institutions and industry players are further enhancing technological advancements in the field.

Vietnam Microfluidics Market Challenges:

High Cost of Microfluidics Devices: In 2023, the average cost of a microfluidic diagnostic device was around USD 15,000, making it difficult for smaller healthcare facilities to afford. This cost barrier limits the widespread adoption of microfluidics technology, particularly in rural areas, thereby constraining market growth.

Limited Technical Expertise: There is a shortage of skilled professionals proficient in operating and maintaining microfluidics devices in Vietnam. The Vietnam Ministry of Education reported that in 2024, only 1,500 medical professionals had specialized training in microfluidics technology. This lack of technical expertise hampers the effective utilization of microfluidics devices, affecting the overall market growth and efficiency of diagnostic procedures.

Vietnam Microfluidics Market Government Initiatives:

Healthcare Innovation Program 2023-2028: In 2023, the Vietnamese government launched the Healthcare Innovation Program, and invested USD 200 million to advance medical technology, including microfluidics. This program aims to modernize healthcare facilities, support local startups, and promote R&D in diagnostics, thereby fostering growth in the microfluidics market and enhancing the country's healthcare capabilities.

National Health Insurance Expansion: In 2024, the Vietnamese government expanded the National Health Insurance program to cover advanced diagnostic procedures, including those utilizing microfluidics technology. This expansion ensures that a larger portion of the population has access to modern diagnostic tools, increasing the demand for microfluidics devices and driving market growth.

Vietnam Microfluidics Future Market Outlook

The Vietnam microfluidics market is expected to grow in the coming years. The market is also likely to shift towards more organized with established players and online platforms expanding their reach.

Vietnam Microfluidics Future Market Trends

Integration of AI and Microfluidics: Over the next five years, the integration of artificial intelligence (AI) with microfluidics technology will transform diagnostics and healthcare delivery in Vietnam. AI-driven microfluidics devices will enable more precise and faster diagnostic results, improving patient outcomes and driving market growth. By 2028, AI-powered diagnostics is expected to be a standard in Vietnamese healthcare.

Growth in Home-Based Diagnostics: The trend towards home-based diagnostics will gain momentum, driven by the convenience and efficiency it offers. Microfluidics technology will enable the development of portable and easy-to-use diagnostic devices for home use. By 2028, the market for home-based microfluidics diagnostic devices is expected to expand, providing patients with accessible healthcare solutions.
Please Note: It will take 5-7 business days to complete the report upon order confirmation